For this purpose we measured at early time after treatment the uptake of [18F]FLT and [18F]VC701 radiopharmaceuticals targeting thymidine kinase 1 (TK1) and Translocator Protein 18 kDa (TSPO) which are receptors associated with glioma malignancy. Here, TK1 is linked to glioma.